Scott Bizily, CLO of 4D Molecular Therapeutics FDMT, has filed 0 purchases and 28 sales on the open market. Over the past 12 months that comes to a net sale of $225.7K. The latest trade was on 06/23.

SB

SB

Scott Bizily

Chief Legal Officer

Company

4D Molecular Therapeutics FDMT

First filing

23/02/14

Trades

104 trades

Buys / sales

0 / 28

12-month net buying

−$225.7K

Last trade

06/23

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	06/23	06/25	9,810 sh	$12.00	$117,720	−53.2%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	25/12/16	25/12/19	1,635 sh	$10.90	$17,821.5	−31.3%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	25/11/17	25/11/19	1,635 sh	$10.59	$17,314.65	−31.3%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	25/10/24	25/10/27	2,678 sh	$12.00	$32,136	−42.7%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	25/10/16	25/10/20	1,635 sh	$10.17	$16,627.95	−24.0%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	25/10/09	25/10/14	2,408 sh	$10.00	$24,080	−31.7%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	25/09/23	25/09/26	2,407 sh	$8.00	$19,256	−24.1%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/09/16	24/09/18	500 sh	$16.33	$8,165	−6.9%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/08/19	24/08/21	500 sh	$15.00	$7,500	−6.9%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/07/16	24/07/18	1,750 sh	$27.11	$47,442.5	−20.5%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/07/11	24/07/15	1,996 sh	$25.00	$49,900	−22.7%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/07/01	24/07/03	4,248 sh	$21.36	$90,737.28	−71.0%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/06/17	24/06/20	1,750 sh	$23.71	$41,492.5	−50.2%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/05/16	24/05/20	1,750 sh2 trades	$25.45avg.	$44,536.47	−50.2%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/04/16	24/04/18	1,750 sh	$25.74	$45,045	−50.2%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/04/01	24/04/03	8,153 sh	$31.78	$259,102.34	−82.4%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/03/27	24/03/29	5,833 sh	$35.04	$204,388.32	−77.1%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/03/18	24/03/20	1,750 sh	$31.27	$54,722.5	−50.2%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/02/27	24/02/29	1,909 sh	$30.00	$57,270	−52.4%
4D Molecular TherapeuticsFDMT	Open-market sale10b5-1 plan	24/02/16	24/02/21	1,750 sh	$27.67	$48,422.5	−50.2%